Paragon's Har­mo­ny Bio­sciences brings in $330M of debt cap­i­tal and eq­ui­ty, look­ing to ex­pand nar­colep­sy drug la­bel

Jeff Aronin’s Har­mo­ny Bio­sciences is ring­ing in a new fi­nanc­ing agree­ment, one that’s bring­ing in hun­dreds of mil­lions of dol­lars.

The Ply­mouth Meet­ing, PA-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER